• Pārskats
  • Aptaukošanās izplatība
  • Iedzīvotāju sadalījums
  • Ietekmējošie faktori
  • Blakusslimības
  • Politikas (pieejamas tikai angļu valodā)
  • Contextual factors
Notiek datu ielāde –  lūdzu, uzgaidiet

Aptaukošanās izplatība

Pieaugušie, 2023

Apsekojuma veids:Pašu ziņojums
Vecums:18+
Izlases lielums:Database currently offline tbc
Aptvertā teritorija:Valsts
Atsauces:Behavioral Risk Factor Surveillance System 2023. Centers for Disease Control and Prevention. Adult Obesity Prevalence Maps. U.S. Dept of Health and Human Services; 2023. Available at https://www.cdc.gov/brfss/annual_data/annual_data.htm (last accessed 05.02.25)
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Bērni, 2010-2011

Apsekojuma veids:Mērītā vērtība
Vecums:12
Izlases lielums:1582
Atsauces:Elías-Boneta AR, Toro MJ, Garcia O, Torres R, Palacios C. High prevalence of overweight and obesity among a representative sample of Puerto Rican children. BMC Public Health. 2015 Mar 5;15:219. doi: 10.1186/s12889-015-1549-0. PMID: 25885462; PMCID: PMC4358900. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358900/ (last accessed 09.03.22)
Piezīmes (pieejamas tikai angļu valodā):A probabilistic sample of 133 schools was selected from a total of 1,843 schools. Ten boys and ten girls were randomly selected from each school using the official student lists provided by the school’s administration. The required sample size was 2,600 children. A total of 1,734 children were contacted and invited to participate, however, some of the selected schools were inactive and others had merged. 152 children were excluded due to school absences and failure to obtain their parent’s written consent.
Definīcijas (pieejamas tikai angļu valodā):Children were categorized as overweight, or obese using the Center for Disease Control and Prevention's age and gender specific growth charts.
Cutoffs:CDC

Liekais svars/aptaukošanās pēc izglītības

Pieaugušie, 2005-2007

Apsekojuma veids:Mērītā vērtība
Vecums:45-52
Izlases lielums:840
Aptvertā teritorija:Regional - San Juan Metropolitan Area
Atsauces:Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in San Juan Metropolitan Area, Puerto Rico https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823746/ (last accessed 09.03.22)
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Liekais svars/aptaukošanās pēc vecuma

Pieaugušie, 2005-2007

Apsekojuma veids:Mērītā vērtība
Izlases lielums:840
Aptvertā teritorija:Regional - San Juan Metropolitan Area
Atsauces:Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in San Juan Metropolitan Area, Puerto Rico https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823746/ (last accessed 09.03.22)
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Double burden of underweight & overweight

Pieaugušie, 2022

Apsekojuma veids:Mērītā vērtība
Vecums:20+
Atsauces:NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2.
Piezīmes (pieejamas tikai angļu valodā):Age Standardised estimates
Definīcijas (pieejamas tikai angļu valodā):Combined prevalence of BMI<18.5 kg/m² and BMI>=30 kg/m² (double burden of underweight and obesity)

Bērni, 2022

Apsekojuma veids:Mērītā vērtība
Vecums:5-19
Atsauces:NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2.
Piezīmes (pieejamas tikai angļu valodā):Age standardised estimates
Definīcijas (pieejamas tikai angļu valodā):Combined prevalence of BMI < -2SD and BMI > 2SD (double burden of thinness and obesity)
Cutoffs:BMI < -2SD and BMI > 2SD

Nepietiekamas fiziskās aktivitātes

Pieaugušie, 2022

Apsekojuma veids:Pašu ziņojums
Vecums:18+
Aptvertā teritorija:Valsts
Atsauces:WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-)
Definīcijas (pieejamas tikai angļu valodā):Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent.

Vīrieši, 2022

Apsekojuma veids:Pašu ziņojums
Vecums:18+
Aptvertā teritorija:Valsts
Atsauces:WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-)
Definīcijas (pieejamas tikai angļu valodā):Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent.

Sievietes, 2022

Apsekojuma veids:Pašu ziņojums
Vecums:18+
Aptvertā teritorija:Valsts
Atsauces:WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-)
Definīcijas (pieejamas tikai angļu valodā):Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent.

Estimated per capita fruit intake

Pieaugušie, 2017

Apsekojuma veids:Mērītā vērtība
Vecums:25+
Atsauces:Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
Definīcijas (pieejamas tikai angļu valodā):Estimated per-capita fruit intake (g/day)

Aptuvenais pārstrādātas gaļas patēriņš uz vienu iedzīvotāju

Pieaugušie, 2017

Apsekojuma veids:Mērītā vērtība
Vecums:25+
Atsauces:Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
Definīcijas (pieejamas tikai angļu valodā):Estimated per-capita processed meat intake (g per day)

Estimated per capita whole grains intake

Pieaugušie, 2017

Apsekojuma veids:Mērītā vērtība
Vecums:25+
Atsauces:Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
Definīcijas (pieejamas tikai angļu valodā):Estimated per-capita whole grains intake (g/day)

Garīgā veselība – depresijas traucējumi

Pieaugušie, 2021

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definīcijas (pieejamas tikai angļu valodā):Number living with depression per 100,000 population (adults 20+ years)

Vīrieši, 2021

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definīcijas (pieejamas tikai angļu valodā):Number living with depression per 100,000 population (adults 20+ years)

Sievietes, 2021

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definīcijas (pieejamas tikai angļu valodā):Number living with depression per 100,000 population (adults 20+ years)

Bērni, 2021

Aptvertā teritorija:Valsts
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definīcijas (pieejamas tikai angļu valodā):Number living with depressive disorder per 100,000 population (Under 20 years of age)

Zēni, 2021

Aptvertā teritorija:Valsts
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definīcijas (pieejamas tikai angļu valodā):Number living with depressive disorder per 100,000 population (Under 20 years of age)

Meitenes, 2021

Aptvertā teritorija:Valsts
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definīcijas (pieejamas tikai angļu valodā):Number living with depressive disorder per 100,000 population (Under 20 years of age)

Garīgā veselība – trauksmes problēmas

Pieaugušie, 2021

Vecums:20+
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
Definīcijas (pieejamas tikai angļu valodā):Number living with anxiety per 100,000 population

Vīrieši, 2021

Vecums:20+
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
Definīcijas (pieejamas tikai angļu valodā):Number living with anxiety per 100,000 population

Sievietes, 2021

Vecums:20+
Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
Definīcijas (pieejamas tikai angļu valodā):Number living with anxiety per 100,000 population

Bērni, 2021

Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)

Zēni, 2021

Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)

Meitenes, 2021

Atsauces:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)

Barības vada vēzis

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Indicence per 100,000

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Indicence per 100,000

Vīrieši, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Sievietes, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Krūts dziedzera vēzis

Sievietes, 2022

Vecums:20
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Kolorektālais vēzis

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Vīrieši, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Sievietes, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Aizkuņģa dziedzera vēzis

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Vīrieši, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Sievietes, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Žultspūšļa vēzis

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Indicence per 100,000

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Indicence per 100,000

Vīrieši, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Sievietes, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Nieru vēzis

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Vīrieši, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Sievietes, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Dzemdes vēzis

Sievietes, 2022

Vecums:20+
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Sievietes, 2020

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2289
Definīcijas (pieejamas tikai angļu valodā):Age-standardized indicence rates per 100 000

Diabēta izplatība

Pieaugušie, 2024

Atsauces:Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium:International Diabetes Federation, 2025. http://www.diabetesatlas.org

Pieaugušie, 2021

Vecums:20-79
Aptvertā teritorija:Valsts
Atsauces:Reproduced with kind permission International Diabetes Federation.  IDF Diabetes Atlas, 10th edn. Brussels, Belgium:International Diabetes Federation, 2021. http://www.diabetesatlas.org
Definīcijas (pieejamas tikai angļu valodā):Age-adjusted comparative prevalence of diabetes, %

Pieaugušie, 2019

Vecums:20-79
Atsauces:Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels,Belgium: 2019. Available at: https://www.diabetesatlas.org
Definīcijas (pieejamas tikai angļu valodā):Diabetes age-adjusted comparative prevalence (%).

Pieaugušie, 2017

Atsauces:Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org
Definīcijas (pieejamas tikai angļu valodā):Diabetes age-adjusted comparative prevalence (%).

Ovarian Cancer

Sievietes, 2022

Vecums:20+
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Leukemia

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Leukemia

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Liver and intrahepatic bile duct Cancer

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Multiple Myeloma

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Indicence per 100,000
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Indicence per 100,000
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Non Hodgkin Lymphoma

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000
Ja nav norādīts citādi, liekais svars attiecas uz ĶMI no 25 kg līdz 29,9 kg/m², aptaukošanās attiecas uz ĶMI, kas lielāks par 30 kg/m².

Thyroid Cancer

Vīrieši, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Sievietes, 2022

Vecums:20+
Aptvertā teritorija:Valsts
Atsauces:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definīcijas (pieejamas tikai angļu valodā):Incidence per 100,000

Policies, Interventions and Actions

Ley de Transformación al Sistema Contributivo del Estado Libre Asociado de Puerto Rico. (Transformation to the fiscal system of the Free Associate State of Puerto Rico)

A tax of an additional 14 cents per litre of soda is proposed by Luis Gándara to the Deputies Chamber. It proposes to use the revenue to improve minors´ (children's) life conditions and is part of the Fiscal Reform. Also, a 14 cents per pound or per fraction of a pound will be imposed to all sugars (regardless of type).

Categories:Taxation/Subsidies on Food or Beverages or law relating to public health
Year(s):2015 (ongoing)
Target age group:Pieaugušie un bērni
Organisation:Ministry of Finance
Find out more:www.hacienda.pr.gov

Law No. 120

Law to prohibit fat content Hydrogenated vegetable, known as trans fats, from all foods prepared and sold by food establishments in Puerto Rico

Categories:Evidence of Marketing Guidelines/Policy
Year(s):2007 (ongoing)
Target age group:Pieaugušie un bērni
Organisation:Legislative Assembly
Linked document:Download linked document

No actions could be found for the above criteria.

Contextual factors

Disclaimer: These contextual factors should be interpreted with care. Results are updated as regularly as possible and use very specific criteria. The criteria used and full definitions are available for download at the bottom of this page.

Tap on a tick to find out more about policies influencing this factor.

Labelling

Is there mandatory nutrition labelling?Absent
Front-of-package labelling?Absent
Back-of-pack nutrition declaration?Absent
Color coding?Absent
Warning label?Absent

Regulation and marketing

Are there fiscal policies on unhealthy products?Absent
Tax on unhealthy foods?Absent
Tax on unhealthy drinks?Absent
Are there fiscal policies on healthy products?Absent
Subsidy on fruits?Absent
Subsidy on vegetables?Absent
Subsidy on other healthy products?Absent
Mandatory limit or ban of trans fat (all settings)?Present
Mandatory limit of trans fats in place (all settings)? Absent
Ban on trans-fats or phos in place (all settings)? Present
Are there any mandatory policies/marketing restrictions on the promotion of unhealthy food/drinks to children?Absent
Mandatory restriction on broadcast media?Absent
Mandatory restriction on non-broadcast media?Absent
Voluntary policies/marketing restrictions on the promotion of unhealthy food/drinks to children?Absent
Are there mandatory standards for food in schools?Absent
Are there any mandatory nutrient limits in any manufactured food products?Absent
Nutrition standards for public sector procurement?Absent

Political will and support

National obesity strategy or nutrition and physical activity national strategy?Absent
National obesity strategy?Absent
National childhood obesity strategy?Absent
Comprehensive nutrition strategy?Absent
Comprehensive physical activity strategy?Absent
Evidence-based dietary guidelines and/or RDAs?Absent
National target(s) on reducing obesity?Absent
Promotion of breastfeeding?Absent

Monitoring and surveillance

Monitoring of the prevalence and incidence for the main obesity-related NCDs and risk factors?Present
Within 5 years?Absent

Governance and resource

Multi-sectoral national co-ordination mechanism for obesity or nutrition (including obesity)?Absent

Key

Present
Present (voluntary)
Incoming
Absent
Unknown

Last updated November 27, 2022

See more policies here

Download contextual factors as a PDF Contextual factors definitions

Feedback

Are you finding the information on these pages useful?
Yes
No
N/A

Thank you for feeding back to World Obesity.

If you have any further feedback or suggestions please email us at obesity@worldobesity.org.

Close
Loading